ABT (Abbott Laboratories Inc.) רווח למניה לשנה מתגלגלת

The YoY growth in net income per share over the last 12 months demonstrates the scaling efficiency of glucose sensors at Abbott Laboratories (ABT), where the current status is -66.00. The company's strategy relies on expanding its portfolio of innovative monitoring systems to drive organic growth. Business stability is bolstered by a streamlined delivery network that ensures the integrity of high-precision instruments during transport to clinics.

The market values Abbott Laboratories (ABT) as a stable asset with high capitalization potential. This indicator measures the percentage change in net earnings per share over the last twelve months, eliminating temporary reporting gaps. By analyzing the current state of annual EPS TTM growth, an investor can see the efficiency of R&D investments in glucose monitoring systems. Such metrics are characteristic of technological leaders within the healthcare sector.